CB Issuance Amount Halved, Terms Revised
차AI헬스케어
025620
Signal Score
Historical Avg Return (5d)
+0.31%
Data Coverage
100%n=2386
Risk-adjusted indicator based on 2386 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • CB Issuance Amount (Post-amendment): 2,500,500,000 KRW (Previously 5,000,000,000 KRW)
- • Shares from Conversion (Post-amendment): 200,633 Shares (Previously 401,187 Shares)
- • Dilution Rate (Post-amendment): 1.10% (Previously 2.20%)
- • Surface Interest Rate: 0% (Previously 5%)
- • Maturity Interest Rate: 1% (Previously 9%)
AI Analysis Summary
CHA AI Healthkare Co.,Ltd. announced an amendment to its convertible bond (CB) issuance. The total CB issuance amount has been reduced by approximately 50% from 5,000,000,000 KRW to 2,500,500,000 KRW. Consequently, the number of shares convertible from the new CBs has also decreased from 401,187 shares to 200,633 shares, reducing the potential dilution rate from 2.20% to 1.10% of total outstanding shares. The interest rates were significantly lowered, with the surface interest rate now 0% (from 5%) and the maturity interest rate 1% (from 9%). The purpose of the funds has been revised from 'Operating funds and Investment funds' totaling 5,000,000,000 KRW to solely 'Investment funds' of 2,501,000,000 KRW. While the reduced dilution is positive, the lower interest rates might make the CB less attractive to investors, potentially indicating a weaker bargaining position or a shift in market conditions. The overall impact is neutral as reduced dilution is offset by less favorable bond terms.
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.